Clinical Trial Update: A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen [Phase 1]

View source ↗

Summary

A completed Phase 1 study investigated whether custirsen alters the blood levels of paclitaxel when administered together in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Custirsen (custirsen)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Achieve Life Sciences | Conditions: Cancer | Phase 1 | Status: COMPLETED